ArticleFrontiers in immunology2025

Real-world evidence of the effectiveness and utilization of subcutaneous C1INH long-term prophylaxis in patients with HAE in Spain and Germany.

Marcus Maurer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.